Skip to main content
. 2020 Jul 14;35(5):1031–1044. doi: 10.3904/kjim.2020.078

Table 2.

Key recommendations for supportive treatment and survivorship care for SCCHN

Pre-treatment evaluation
Multidisciplinary approach Assessment and evaluation by multiple subspecialties of oncology
Possible treatment de-intensification or organ preservation for HPV-positive or locoregional disease
Consider reconstruction if extensive surgical resection is required
Speech/language therapy Voice therapy (use electrolarynx if necessary)
Swallow exercise
Close follow-up and objective assessment of speech and swallowing function (patient-reported symptoms do not accurately reflect the level of morbidity)
Nutrition Prophylactic or elective G tube feeding
Dental and oral care
Survivorship care
Cancer surveillance Cancer-specific history and physical exam every 1 to 3 months for the first year after the primary treatment, every 2 to 6 months in the second year, every 4 to 8 months in the 3rd to 5th years, and annually after the 5th year
Patient education about the signs of early recurrence
Adequate and timely referral to oncologist or ENT specialist if detailed exam is needed
Adhere to national guidelines for second primary cancer prevention
Substance abuse Proper counseling on smoking cessation and alcohol abstinence
Screen for underlying mood disorder
Referral to cessation resources or psychiatrist if needed
Body and self-image Assessment of body and self-image concerns
Referral to psychiatrist if needed
Mood disorder Evaluate survivors for depression, anxiety and screen for relevant social/financial/emotional distresses
Social care for financial or employment challenges
Addiction recovery assistance for substance abuse
Pharmacologic treatment as indicated
Timely referral to psychiatrist

SCCHN, squamous cell carcinoma of head and neck; HPV, human papilloma virus; ENT, ear nose throat.